Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 2Pain 1Osteosarcoma 1Lymphoma 1Endocrine Gland Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Analgesia 4Psychiatric Rehabilitation 3Radiotherapy 2Morphine 2Fentanyl 2Therapeutics 1Restraint, Physical 1Psilocybin 1Photochemotherapy 1Pharmacogenomic Testing 1Palliative Care 1Oxycodone 1Nutritional Support 1Music Therapy 1Methadone 1Massage 1Laser Therapy 1Ketamine 1Genistein 1Early Intervention, Educational 1Dextromethorphan 1Cryosurgery 1Celecoxib 1Acupuncture Therapy 1Acetaminophen 1Absorptiometry, Photon 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × Psilocybin × Dermatologic × Clear all
NCT00979693 2023-12-26

Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma

Multidisciplinary Association for Psychedelic Studies

Phase 2 Withdrawn
Dermatologic

Anxiety Disorders, Depression, Melanoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡